IVAX Pharmaceuticals is recalling approximately 50 bottles of Terazosin Hydrochloride Capsules (1 mg) because the medication failed to meet dissolution standards during stability testing at the 18-month mark. Terazosin Hydrochloride is a prescription medication used to treat symptoms of an enlarged prostate and high blood pressure. When a drug fails dissolution testing, it may not break down and release into the bloodstream as intended, which can lead to reduced effectiveness or inconsistent treatment of the underlying condition. Consumers currently taking this medication should contact their healthcare provider or pharmacist for guidance.
The capsules may not dissolve properly in the body, which can prevent the active medication from being absorbed correctly and potentially lead to poorly controlled blood pressure or urinary symptoms.
Healthcare consultation and pharmacy refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.